ArticleHepatology international2024

Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma.

Hiroyuki Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.